Taurus Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-960
Closed -$229K 101
2017
Q1
$229K Sell
960
-9,862
-91% -$2.3M 0.04% 87
2016
Q4
$2.27M Sell
10,822
-21,585
-67% -$4.47M 0.41% 49
2016
Q3
$7.46M Sell
32,407
-15,350
-32% -$3.75M 1.35% 36
2016
Q2
$11M Buy
47,757
+974
+2% +$225K 1.94% 26
2016
Q1
$12.5M Sell
46,783
-66
-0.1% -$18.9K 2.32% 19
2015
Q4
$14.6M Buy
46,849
+505
+1% +$150K 2.75% 9
2015
Q3
$12.6M Buy
46,344
+283
+0.6% +$86.9K 2.43% 12
2015
Q2
$14M Buy
46,061
+11,691
+34% +$3.49M 2.54% 9
2015
Q1
$10.2M Buy
+34,370
New +$9.8M 1.91% 22

Other funds holding AGN

Taurus Asset Management's AGN Position: Q2 2017 in Review

Taurus Asset Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 960 shares — an estimated $229K sold.

Taurus Asset Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $14.6M in Q4 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Taurus Asset Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Taurus Asset Management sold 960 Allergan plc shares in Q2 2017, an estimated $229K.
  • Taurus Asset Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Taurus Asset Management's Allergan plc position peaked at $14.6M in Q4 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Taurus Asset Management's 13F filing for Q2 2017, filed 3 Aug 2017.